Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1525-1497
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report ; volume:37 ; number:5 ; day:6 ; month:1 ; year:2022 ; pages:1281-1285 ; date:4.2022
Journal of general internal medicine ; 37, Heft 5 (6.1.2022), 1281-1285, 4.2022
- Creator
-
Leyde, Sarah
Suen, Leslie
Pratt, Lisa
DeFries, Triveni
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11606-021-07295-2
- URN
-
urn:nbn:de:101:1-2022061921595610767763
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leyde, Sarah
- Suen, Leslie
- Pratt, Lisa
- DeFries, Triveni
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Acute kidney injury in hospitalized children with sickle cell anemia
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Acute kidney injury in hospitalized children with sickle cell anemia
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Acute kidney injury in hospitalized children with sickle cell anemia